These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8238729)

  • 1. Atypical fibroxanthoma. Multiple immunohistologic profiles.
    Longacre TA; Smoller BR; Rouse RV
    Am J Surg Pathol; 1993 Dec; 17(12):1199-209. PubMed ID: 8238729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX.
    Harding-Jackson N; Sangueza M; Mackinnon A; Suster S; Plaza JA
    Am J Dermatopathol; 2015 Jul; 37(7):509-14; quiz 515-6. PubMed ID: 26098709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical fibrous histiocytoma of the skin: clinicopathologic analysis of 59 cases with evidence of infrequent metastasis.
    Kaddu S; McMenamin ME; Fletcher CD
    Am J Surg Pathol; 2002 Jan; 26(1):35-46. PubMed ID: 11756767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign fibrous histiocytoma (dermatofibroma) of the face: clinicopathologic and immunohistochemical study of 34 cases associated with an aggressive clinical course.
    Mentzel T; Kutzner H; Rütten A; Hügel H
    Am J Dermatopathol; 2001 Oct; 23(5):419-26. PubMed ID: 11801774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined dermatofibroma: co-existence of two or more variant patterns in a single lesion.
    Zelger BG; Sidoroff A; Zelger B
    Histopathology; 2000 Jun; 36(6):529-39. PubMed ID: 10849095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell atypical fibroxanthoma:a clinicopathologic study.
    Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
    J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas.
    Prieto VG; Reed JA; Shea CR
    J Cutan Pathol; 1995 Aug; 22(4):336-41. PubMed ID: 7499573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical fibroxanthoma. An unusual variant with osteoclast-like giant cells.
    Tomaszewski MM; Lupton GP
    Am J Surg Pathol; 1997 Feb; 21(2):213-8. PubMed ID: 9042289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal and subcutaneous variants of plexiform fibrohistiocytic tumor.
    Zelger B; Weinlich G; Steiner H; Zelger BG; Egarter-Vigl E
    Am J Surg Pathol; 1997 Feb; 21(2):235-41. PubMed ID: 9042292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plexiform fibrohistiocytic tumour: clinicopathological, immunohistochemical and ultrastructural analysis in favour of a myofibroblastic lesion.
    Hollowood K; Holley MP; Fletcher CD
    Histopathology; 1991 Dec; 19(6):503-13. PubMed ID: 1723956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of CD163 in cutaneous spindle cell lesions.
    Pouryazdanparast P; Yu L; Cutlan JE; Olsen SH; Fullen DR; Ma L
    J Cutan Pathol; 2009 Aug; 36(8):859-64. PubMed ID: 19040468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.
    Gleason BC; Fletcher CD
    Am J Surg Pathol; 2008 Mar; 32(3):354-62. PubMed ID: 18300816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD.
    Moosavi C; Jha P; Fanburg-Smith JC
    Ann Diagn Pathol; 2007 Oct; 11(5):313-9. PubMed ID: 17870015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myofibroblastic differentiation in atypical fibroxanthomas occurring on sun-exposed skin and in a burn scar: an ultrastructural and immunohistochemical study.
    Ito A; Yamada N; Yoshida Y; Morino S; Yamamoto O
    J Cutan Pathol; 2011 Aug; 38(8):670-6. PubMed ID: 21623865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of immunohistochemistry in atypical cutaneous fibrous histiocytoma.
    Wilk M; Zelger BG; Nilles M; Zelger B
    Am J Dermatopathol; 2004 Oct; 26(5):367-71. PubMed ID: 15365367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical fibroxanthoma with lymphomatoid reaction.
    Zheng R; Ma L; Bichakjian CK; Lowe L; Fullen DR
    J Cutan Pathol; 2011 Jan; 38(1):8-13. PubMed ID: 21039743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical fibroxanthoma with osteoclast-like multinucleated giant cells.
    Khan ZM; Cockerell CJ
    Am J Dermatopathol; 1997 Apr; 19(2):174-9. PubMed ID: 9129703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
    Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
    J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.